Ionis Pharmaceuticals (IONS) Reports In-Line Q3 EPS

November 2, 2023 7:03 AM EDT

Ionis Pharmaceuticals (NASDAQ: IONS) reported Q3 EPS of ($1.03), in-line with the analyst estimate of ($1.03). Revenue for the quarter came in at $144 million versus the consensus estimate of $132.91 million.

For earnings history and earnings-related data on Ionis Pharmaceuticals (IONS) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities